SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sandu Pharmaceuticals informs about disclosure

21 Jan 2025 Evaluate

Pursuant to the provisions of Regulation 30 read with sub-para 20 of Para A of Part A of Schedule III of the Listing Regulations, Sandu Pharmaceuticals has informed that the Company is in receipt of an final Order passed by the Office of the Department of Commercial Taxes, Government of Goa 0/0 Deputy Commissioner of State Tax Mapusa Ward, Mapusa Goa, in respect of the appeal made by Company for refund of excess tax paid which has been sanctioned amounting to Rs 27,873/-.

The above information is a part of company’s filings submitted to BSE.

Sandu Pharmaceutical Share Price

38.10 -0.70 (-1.80%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×